Keyword → MDT

Wall Street Volatility Spikes as Stagflation Fears Grip Investors

Markets are grappling with a potentially dangerous combination of slowing economic growth and rising energy costs. Investors are increasingly worried that the U.S. economy could face stagflation, a scenario where inflation remains elevated even as growth weakens. The outlook has triggered sharp moves across equities, commodities and bond markets as traders reposition portfolios to navigate an uncertain macroeconomic environment.

Medtronic Posts Strongest Revenue Growth in Ten Quarters, Reiterates Full-Year Outlook

Medtronic reported third-quarter fiscal 2026 revenue of $9.02 billion, an 8.7% year-over-year increase representing the company's highest enterprise revenue growth in ten quarters, beating analyst estimates of $8.89 billion. Non-GAAP diluted EPS of $1.36 beat consensus by three cents, and the medical device giant reiterated full-year organic revenue growth guidance of approximately 5.5% despite a projected $185 million tariff headwind.

Tariff Burden on U.S. Households Hits $1,300 as Corporate Guidance Flags Mounting Trade Policy Headwinds

Tax Foundation analysis confirms that President Trump's cumulative tariff regime now represents the largest U.S. tax increase as a share of GDP since 1993, imposing an average annual burden of $1,300 per household in 2026. With Goldman Sachs estimating American companies and consumers bear over three-quarters of tariff costs, earnings guidance across industrials, consumer discretionary, and healthcare is increasingly reflecting this structural drag on margins and consumer demand.

OPKO Health Schedules Q4 Earnings Report, Shares React to Upcoming Guidance

OPKO Health announced plans to release its fourth-quarter and full-year 2025 financial results later this month, expected to include commentary on future revenue and profitability. The upcoming earnings call could influence sentiment among healthcare and biotech investors amid broader market volatility.

Philips Reports 2025 Results With Margin Expansion and 2026 Outlook Targets

Royal Philips published its full-year 2025 financial results, highlighting accelerated growth, expanding profit margins and robust cash flow. The company also unveiled strategic targets for 2026-2028, emphasizing innovation and operational efficiency across health technology segments.